Glazer Capital LLC’s Hims & Hers Health HIMS Stock Holding History

Glazer Capital LLC’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500	Closed	-$14K	–	325
2025 Q2	$14K	Buy	+500	New	+$22.6K	﹤0.01%	226

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glazer Capital LLC's HIMS Position: Q4 2020 in Review

Glazer Capital LLC sold out of Hims & Hers Health (HIMS) in Q4 2020, closing a stake of 460,000 shares — an estimated $5.41M sold.

Glazer Capital LLC first reported a position in HIMS in Q1 2020 and held it in 3 quarters. The position peaked at $5.63M in Q2 2020. 42 funds tracked by Wall St. Rank hold HIMS as of Q4 2020.

Glazer Capital LLC reported no remaining Hims & Hers Health position as of Q4 2020 after selling out during the quarter.
Glazer Capital LLC sold 460,000 Hims & Hers Health shares in Q4 2020, an estimated $5.41M.
Glazer Capital LLC first reported a position in Hims & Hers Health in Q1 2020 and held it in 3 quarters.
Glazer Capital LLC's Hims & Hers Health position peaked at $5.63M in Q2 2020.
42 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2020.

Based on Glazer Capital LLC's 13F filing for Q4 2020, filed 16 Feb 2021.